Cargando…
Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
BACKGROUND: Although antimicrobial resistance is increasingly common in equine medicine, molecular and epidemiological data remains scarce. OBJECTIVES: We estimated the prevalence of, and risk factors for, shedding of multidrug resistant (MDR), extended spectrum β‐lactamase (ESBL)‐producing, and Amp...
Autores principales: | de Lagarde, Maud, Larrieu, Caroline, Praud, Karine, Schouler, Catherine, Doublet, Benoît, Sallé, Guillaume, Fairbrother, John M., Arsenault, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430864/ https://www.ncbi.nlm.nih.gov/pubmed/30648296 http://dx.doi.org/10.1111/jvim.15415 |
Ejemplares similares
-
Prevalence, Risk Factors, and Characterization of Multidrug Resistant and ESBL/AmpC Producing Escherichia coli in Healthy Horses in Quebec, Canada, in 2015–2016
por: de Lagarde, Maud, et al.
Publicado: (2020) -
Epidemiology and high incidence of metallo-β-lactamase and AmpC-β-lactamases in nosocomial Pseudomonas aeruginosa
por: Muddassir, Maria, et al.
Publicado: (2021) -
Detection of AmpC β Lactamases in Gram-negative Bacteria
por: Gupta, Gunjan, et al.
Publicado: (2014) -
Challenges in detection of AmpC β-lactamases among Enterobacteriaceae
por: Joseph, Noyal Mariya, et al.
Publicado: (2013) -
Detection of AmpC β-lactamases in gram-negative bacteria
por: Zhou, Qian, et al.
Publicado: (2022)